Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

SHA:688399 Revenue

Jiangsu Bioperfectus Technologies had revenue of 81.46M CNY in the quarter ending September 30, 2026, a decrease of -0.57%. This brings the company's total for the last twelve months to 310.43M, down -8.44% year-over-year. In the year 2025, Jiangsu Bioperfectus Technologies had annual revenue of 339.05M, down -3.02%. That makes Jiangsu Bioperfectus Technologies the 28,471st largest company in the world by revenue and 4,856th in China.

• Revenue (ttm): 310.43M
• Revenue Growth: -8.44%
• P/S Ratio: 9.56
• Revenue / Employee: 534.30K
• Employees: 578
• Market Cap: 2.97B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Diagnostic Reagent 293.23M 93.7%
• Diagnostic Instruments 13.53M 4.3%
• Testing Services 6.10M 1.9%
• Other 17.95K 0.0%

By Geography

Chart

• East China 140.13M 44.8%
• South China 35.60M 11.4%
• Central China 31.89M 10.2%
• Southwest China 27.51M 8.8%
• North China 26.31M 8.4%
• Northwest China 24.15M 7.7%
• Northeast China 14.10M 4.5%
• Other 13.17M 4.2%

Fiscal year ended Dec 31, 2025 See the full SHA:688399 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	339.05M	-10.56M	-3.02%
Dec 31, 2024	349.61M	-53.57M	-13.29%
Dec 31, 2023	403.18M	-5.13B	-92.72%
Dec 31, 2022	5.53B	2.70B	94.95%
Dec 31, 2021	2.84B	1.10B	63.19%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error